Jan 12 (Reuters) – Drugstore chain CVS Health Corp
has started selling a generic version of Impax Laboratories
Inc’s emergency allergy injection, a device similar to
Mylan NV’s controversial Epipen.
The post CVS starts selling Impax’s cheaper emergency allergy shot appeared first on NASDAQ.